FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 70771-1625 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA208954
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsMESALAMINE (.375 g/1)
Marketing started20210813
Package count1

External sources

Source: openFDA. Public-domain (CC0).